Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05566015

Relationship Between Self-compassion and Treatment Adherence in Schizophrenic Spectrum Disorders

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Treatment adherence is defined by the World Health Organisation (WHO) as the extent to which the patient's history of therapeutic drug-taking coincides with the prescribed treatment. In patients suffering from psychiatrical diseases, especially in those who are suffering from schizophrenic spectrum disorders, the quality of treatment adherence has to be improved. Indeed, non adherance to anti-psychotic treatment increases the risk of hospitalization, of substance use, violent behaviour and of functionnal and cognitif impairment. Selfcompassion, which involves being touched by and open to one's own suffering and to heal oneself with kindness and without judgement and self-criticism has never beed studied as a possible factor infuencing treatment adherence. This study aims to evaluate if a link between selfcompassion and treatment adherence exists in patients suffering from schizophrenic spectrum disorders.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaireself-administered questionnaires as well as clinical assessment of schizophrenia symptoms and depression.

Timeline

Start date
2022-09-26
Primary completion
2023-07-01
Completion
2023-07-01
First posted
2022-10-04
Last updated
2023-07-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05566015. Inclusion in this directory is not an endorsement.